中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2015年
9期
26-27
,共2页
缩宫素%子宫肌瘤%超声消融
縮宮素%子宮肌瘤%超聲消融
축궁소%자궁기류%초성소융
oxytocin%uterine fibroids%ultrasound ablation
目的:探讨不同剂量缩宫素对子宫肌瘤血供的影响。方法选取2013年6月至2014年6月因子宫肌瘤拟行超声消融治疗的200例患者,随机分为3组,分别予以缩宫素0.12,0.24,0.36 U/min静脉滴注,观察3组患者静脉滴注缩宫素前后周边动脉和内部动脉血流参数变化,以及生命体征变化和3个月内并发症发生率。结果3组患者静脉滴注缩宫素后周边动脉、内部动脉平均血流速度(Vmean)、收缩期峰值流速(PSV)、管径和血流量均显著下降,阻力指数(RI)显著上升( P<0.05),但组间内部动脉、周边动脉各指标差异不显著( P>0.05)。3组患者静脉滴注缩宫素后的收缩压、舒张压和平均动脉压均显著低于静脉滴注前,而心率显著高于静脉滴注前( P<0.05),但组间各指标差异不显著( P>0.05)。随访3个月3组患者均未发生包括头晕、恶心呕吐、胸闷、腹痛等在内的并发症。结论静脉滴注缩宫素可减少子宫肌瘤血供,改变超声下血流信号参数。
目的:探討不同劑量縮宮素對子宮肌瘤血供的影響。方法選取2013年6月至2014年6月因子宮肌瘤擬行超聲消融治療的200例患者,隨機分為3組,分彆予以縮宮素0.12,0.24,0.36 U/min靜脈滴註,觀察3組患者靜脈滴註縮宮素前後週邊動脈和內部動脈血流參數變化,以及生命體徵變化和3箇月內併髮癥髮生率。結果3組患者靜脈滴註縮宮素後週邊動脈、內部動脈平均血流速度(Vmean)、收縮期峰值流速(PSV)、管徑和血流量均顯著下降,阻力指數(RI)顯著上升( P<0.05),但組間內部動脈、週邊動脈各指標差異不顯著( P>0.05)。3組患者靜脈滴註縮宮素後的收縮壓、舒張壓和平均動脈壓均顯著低于靜脈滴註前,而心率顯著高于靜脈滴註前( P<0.05),但組間各指標差異不顯著( P>0.05)。隨訪3箇月3組患者均未髮生包括頭暈、噁心嘔吐、胸悶、腹痛等在內的併髮癥。結論靜脈滴註縮宮素可減少子宮肌瘤血供,改變超聲下血流信號參數。
목적:탐토불동제량축궁소대자궁기류혈공적영향。방법선취2013년6월지2014년6월인자궁기류의행초성소융치료적200례환자,수궤분위3조,분별여이축궁소0.12,0.24,0.36 U/min정맥적주,관찰3조환자정맥적주축궁소전후주변동맥화내부동맥혈류삼수변화,이급생명체정변화화3개월내병발증발생솔。결과3조환자정맥적주축궁소후주변동맥、내부동맥평균혈류속도(Vmean)、수축기봉치류속(PSV)、관경화혈류량균현저하강,조력지수(RI)현저상승( P<0.05),단조간내부동맥、주변동맥각지표차이불현저( P>0.05)。3조환자정맥적주축궁소후적수축압、서장압화평균동맥압균현저저우정맥적주전,이심솔현저고우정맥적주전( P<0.05),단조간각지표차이불현저( P>0.05)。수방3개월3조환자균미발생포괄두훈、악심구토、흉민、복통등재내적병발증。결론정맥적주축궁소가감소자궁기류혈공,개변초성하혈류신호삼수。
Objective To investigate the effect of different doses of oxytocin on uterine fibroids blood supply. Methods 200 patients with uterine fibroids undergoing ultrasound ablation in our hospital from June 2013 to June 2014 were selected and randomly divided into three groups. Oxytocin was intravenously dripped by a rate of 0. 12, 0. 24 and 0. 36 U/min. The changes of peripheral arterial and internal arterial blood flow parameters before and after intravenous drip of oxytocin were observed in the three groups. The changes of the vital signs before and after intravenous drip of oxytocin and the occurrence rate of complications within three months were observed in the three groups. Results The mean flow velocity ( Vmean ) , peak systolic velocity ( PSV ) , vascular diameter and blood flow in pe-ripheral and internal arteries after intravenous drip of oxytocin in three groups were significantly decreased, the resistance index ( RI ) was significant increased ( P < 0. 05 ); but the internal and peripheral arterial indexes had no statistically significant differences among the three groups ( P > 0. 05 ) . The systolic, diastolic, and mean arterial pressure after intravenous drip of oxytocin in the three groups were significantly lower than those before intravenous drip, while the heart rate was significantly higher than that before intravenous drip ( P <0. 05 );but no statistically significant differences existed among the three groups ( P > 0. 05 ) . No complications including dizziness, nause-a, vomiting, chest tightness, abdominal pain etc. occurred during 3-month follow up period. Conclusion Intravenous drip of oxytocin can reduce the blood supply of uterine fibroids and change the blood flow signals parameters under ultrasound.